Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-04-23FDA Approved: NIACIN — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' NIACIN as an original generic application for nicotinic acid, intended to treat niacin defic…
-
FDA approval · 2014-04-23FDA Approved: NIACIN — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves NIACIN as an original-application generic from Sun Pharmaceutical Industries for the treatment of hyperlipidemia.
-
CLINICAL_TRIALS trial_result · 2014-04-22Clinical Trial Update: A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels [Phase 2]
Phase 2 trial update reporting safety and efficacy results for DRL-17822, a CETP inhibitor, in adults with hyperlipidemia; results were post…
-
FDA approval · 2014-04-21FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the combination product amlodipine besylate and atorvastatin calcium from Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin) [Phase 1]
Phase 1 study evaluating potential drug–drug interactions between Telmisartan/S-Amlodipine and Rosuvastatin completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Effects of Green Tea Extract on Obese Women With High Level of LDL [Phase 3]
Phase 3 clinical trial evaluating the effects of green tea extract in obese women with high LDL cholesterol has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia [NA]
An update on a clinical trial assessing the efficacy and safety of dietary supplements in chronic smokers with mild to moderate hyperlipidem…
-
FDA approval · 2014-03-20FDA Approved: NIACIN — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original abbreviated new drug application for NIACIN, a generic nicotinic acid product.
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia [Phase 3]
A Phase 3 study is being conducted to evaluate the efficacy and safety of Omega-3-acids Ethylesters 90 in patients with hyperlipidemia, incl…
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia [Phase 3]
This document discusses a Phase 3 trial evaluating the efficacy and safety of co-administering telmisartan and rosuvastatin in hypertensive …
-
FDA approval · 2014-03-11FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc. The approval …
-
FDA approval · 2014-03-07FDA Approved: AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM — Original Application (Dr. Reddy's Laboratories Inc)
FDA approved the original application for a generic fixed-dose combination of amlodipine besylate and atorvastatin calcium from Dr. Reddy's …
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management [NA]
A completed clinical trial update describes expanding comparative effectiveness research capabilities through complex patient relationship m…
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: The Effects of a Mediterranean Diet in Pediatric Hyperlipidemia [Phase 1]
A Phase 1 clinical trial evaluating the effects of a Mediterranean diet on pediatric hyperlipidemia has completed.
-
FDA approval · 2014-01-22FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2014-01-22FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc., indicating a…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)
A completed clinical trial evaluating lipid control in hyperlipidemic participants.
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Study of Cholesterol Levels and Types in African Americans With Type 2 Diabetes
A completed study evaluated cholesterol profiles, lipoprotein types, and apolipoprotein levels in African Americans with Type 2 Diabetes, wi…
-
FDA approval · 2013-12-04FDA Approved: FENOFIBRIC ACID — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original application for fenofibric acid, a lipid-lowering agent indicated for certain lipid disorde…
-
FDA approval · 2013-11-29FDA Approved: AMLODIPINE AND ATORVASTATIN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves an original ANDA for AMLODIPINE AND ATORVASTATIN (Mylan Pharmaceuticals Inc.), a generic fixed-dose combination product.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health [NA]
This clinical trial update investigates whether a cardiovascular-health supplement changes total cholesterol levels. Details about the suppl…
-
FDA approval · 2013-11-07FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for amlodipine and atorvastatin (amlodipine besylate and atorvastatin calci…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia [Phase 3]
Phase 3 trial evaluating the combination of telmisartan and simvastatin for hypertension and hyperlipidemia has completed.
-
FDA approval · 2013-10-25FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ZOCOR (simvastatin) submitted by Organon LLC to the existing NDA.
-
FDA approval · 2013-10-18FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Fenofibrate submitted by Lupin Pharmaceuticals, Inc. This indicates a change or addition to …